heart%20failure%20-%20acute
HEART FAILURE - ACUTE
Heart failure is a clinical syndrome caused by cardiac dysfunction usually secondary to myocardial muscle loss or dysfunction.
It is characterized by either left ventricular hypertrophy or dilation or both.
It leads to neurohormonal and circulatory abnormalities.
Acute heart failure is the rapid onset of or change in the signs and symptoms of heart failure.
It arises as a result of cardiac function deterioration in patients previously diagnosed with heart failure or may also be the first presentation of heart failure.
It is characterized by pulmonary congestion, decreased cardiac output and tissue perfusion.
It is a life-threatening condition that needs immediate medical attention.

Heart Failure - Acute Drug Information

Drug Information

Indication: HTN; angina pectoris; MI. Cardiac rhythm disturbances including supraventricular tachycardia. Functional heart...

Indication: HTN, CHD (angina pectoris), stable chronic heart failure w/ reduced systolic left ventricular function in addi...

Indication: 2.5 & 5 mg: Stable chronic heart failure w/ reduced systolic left ventricular function. 5 mg: HTN & CH...

Indication: Stable chronic heart failure w/ reduced systolic left ventricular function in addition to ACE inhibitors, diur...

Indication: HTN, CHD (angina pectoris), stable chronic moderate to severe heart failure w/ reduced systolic ventricular fu...

Indication: HTN.

Indication: 2nd-line treatment of HTN in patients whose BP is inadequately controlled by monotherapy.

Indication: Stable chronic heart failure w/ reduced systolic left ventricular function in addition to ACE inhibitors &...

Indication: HTN, heart failure, post MI.

2  /  12
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.